69
Views
0
CrossRef citations to date
0
Altmetric
Articles

Accuracy of the ‘CUT’ Score for Assessing Malignancy in Bethesda 3 and 4 Thyroid Nodules in North American Population: A Retrospective Study

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , , , , & ORCID Icon show all
Pages 693-699 | Received 06 Jun 2021, Accepted 10 May 2022, Published online: 14 Jul 2022

References

  • Ezzat S, Sarti DA, Cain DR, Braunstein GD. Thyroid incidentalomas. Prevalence by palpation and ultrasonography. Arch Intern Med. 1994;154(16):1838–40. doi:10.1001/archinte.154.16.1838.
  • Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133. doi:10.1089/thy.2015.0020.
  • Mufti ST, Molah R. The bethesda system for reporting thyroid cytopathology: a five-year retrospective review of one center experience. Int J Health Sci . 2012;6(2):159–73. doi:10.12816/0005991.
  • Colombo C, Muzza M, Pogliaghi G, Palazzo S, Vannucchi G, Vicentini L, et al. The thyroid risk score (TRS) for nodules with indeterminate cytology. Endocr Relat Cancer. 2021;28(4):225–35. doi:10.1530/ERC-20-0511.
  • He Y-P, Xu H-X, Zhao C-K, Sun L-P, Li X-L, Yue W-W, et al. Cytologically indeterminate thyroid nodules: increased diagnostic performance with combination of US TI-RADS and a new scoring system. Sci Rep. 2017;7(1):6906. doi:10.1038/s41598-017-07353-y.
  • Mehta S, Kannan S. Approaching indeterminate thyroid nodules in the absence of molecular markers: The BETH-TR Score. Indian J Endocr Metab. 2020;24(2):170–5. doi:10.4103/ijem.IJEM_620_19.
  • Ianni F, Campanella P, Rota CA, Prete A, Castellino L, Pontecorvi A, et al. A meta-analysis-derived proposal for a clinical, ultrasonographic, and cytological scoring system to evaluate thyroid nodules: the “CUT” score. Endocrine. 2016;52(2):313–21. doi:10.1007/s12020-015-0785-5.
  • Tessler FN, Middleton WD, Grant EG, Hoang JK, Berland LL, Teefey SA, et al. ACR Thyroid Imaging, Reporting and Data System (TI-RADS): white paper of the ACR TI-RADS committee. J Am Coll Radiol. 2017;14(5):587–95. doi:10.1016/j.jacr.2017.01.046.
  • Cibas ES, Ali SZ. The 2017 Bethesda system for reporting thyroid cytopathology. Thyroid. 2017;27(11):1341–6. doi:10.1089/thy.2017.0500.
  • Ianni F, Pascucci D, Paragliola RM, Rota CA, Perotti G, Fadda G, et al. Follow-up or surgery for indeterminate thyroid nodules: could the CUT score application be a support for decision-making in the preoperative assessment? Thyroid. 2020;30(1):65–71. doi:10.1089/thy.2018.0649.
  • CD-ROM THE SURF report 2 – who. n.d. Retrieved January 17, 2022, from https://apps.who.int/iris/bitstream/handle/10665/43190/9241593024_eng.pdf.
  • Campanella P, Ianni F, Rota CA, Corsello SM, Pontecorvi A. Quantification of cancer risk of each clinical and ultrasonographic suspicious feature of thyroid nodules: a systematic review and meta-analysis. Eur J Endocrinol. 2014;170(5):R203–11. doi:10.1530/EJE-13-0995.
  • Paes JE, Hua K, Nagy R, Kloos RT, Jarjoura D, Ringel MD. The relationship between body mass index and thyroid cancer pathology features and outcomes: a clinicopathological cohort study. J Clin Endocrinol Metab. 2010;95(9):4244–50. doi:10.1210/jc.2010-0440.
  • Engeland A, Tretli S, Akslen LA, Bjørge T. Body size and thyroid cancer in two million Norwegian men and women. Br J Cancer. 2006;95(3):366–70. doi:10.1038/sj.bjc.6603249.
  • Brindel P, Doyon F, Rachédi F, Boissin J-L, Sebbag J, Shan L, et al. Anthropometric factors in differentiated thyroid cancer in French Polynesia: a case-control study. Cancer Causes Control. 2009;20(5):581–90. doi:10.1007/s10552-008-9266-y.
  • Oh SW, Yoon YS, Shin SA. Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea National Health Insurance Corporation Study. J Clin Oncol. 2005;23(21):4742–54. doi:10.1200/JCO.2005.11.726.
  • de Koster EJ, de Geus-Oei L-F, Dekkers OM, van Engen-van Grunsven I, Hamming J, Corssmit EPM, et al. Diagnostic utility of molecular and imaging biomarkers in cytological indeterminate thyroid nodules. Endocr Rev. 2018;39(2):154–91. doi:10.1210/er.2017-00133.
  • Pinhas S, Tessler I, Bizer LP, Khalilia K, Warman M, Adi M, et al. Validating the 'CUT score' risk stratification tool for indeterminate thyroid nodules using the Bethesda system for reporting thyroid cytopathology. Eur Arch Otorhinolaryngol. 2022;279(1):383–90. doi:10.1007/s00405-021-06783-9.
  • Brito JP, Gionfriddo MR, Al Nofal A, Boehmer KR, Leppin AL, Reading C, et al. The accuracy of thyroid nodule ultrasound to predict thyroid cancer: systematic review and meta-analysis. J Clin Endocrinol Metab. 2014;99(4):1253–63. doi:10.1210/jc.2013-2928.
  • Remonti LR, Kramer CK, Leitão CB, Pinto LCF, Gross JL. Thyroid ultrasound features and risk of carcinoma: a systematic review and meta-analysis of observational studies. Thyroid. 2015;25(5):538–50. doi:10.1089/thy.2014.0353.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.